Busca un médico

Hugo E. Vargas, M.D.

  1. Gastroenterologist
  2. Internist
  3. Transplant Hepatologist
  4. Chair, Trasplantes, Arizona
Solicite una Consulta

Publicaciones

  1. Su M, Jiang Y, Zhao C, Cai Y, Zhang W, Liu J, Tang H, Yan L, Xu Z, Goel A, Kumar A, Asrani S, Shaw J, Vargas H, Keaveny A, Cao Z, Wong F, Choudhury AK, Kamath PS, Topazian M, Torre A, Hayes PC, George J, Idilman R, Seto WK, Desalegn H, Alvares-da-Silva MR, Bush BJ, Thacker LR, Xie Q, Bajaj JS, CLEARED Consortium. Global prevalence and characteristics of infections and clinical outcomes in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED Consortium. Lancet Gastroenterol Hepatol. 2024 Nov; 9 (11):997-1009 Epub 2024 Sept 05
    View PubMed
  2. Clark VC, Strange C, Strnad P, Sanchez AJ, Kwo P, Pereira VM, van Hoek B, Barjaktarevic I, Corsico AG, Pons M, Goldklang M, Gray M, Kuhn B, Vargas HE, Vierling JM, Vuppalanchi R, Brantly M, Kappe N, Chang T, Schluep T, Zhou R, Hamilton J, San Martin J, Loomba R. Fazirsiran for Adults With Alpha-1 Antitrypsin Deficiency Liver Disease: A Phase 2 Placebo Controlled Trial (SEQUOIA). Gastroenterology. 2024 Oct; 167 (5):1008-1018.e5 Epub 2024 July 02
    View PubMed
  3. Louissaint J, Vargas HE. Picture Perfect: Artificial Intelligence in the Management of Hepatic Encephalopathy. Am J Gastroenterol 2024 May 1; 119 (5):801-802 Epub 2024 Feb 16
    View PubMed
  4. Weinberg EM, Wong F, Vargas HE, Curry MP, Jamil K, Pappas SC, Sharma P, Reddy KR. Decreased need for RRT in liver transplant recipients after pretransplant treatment of hepatorenal syndrome-type 1 with terlipressin. Liver Transpl. 2024 Apr 1; 30 (4):347-355 Epub 2023 Oct 09
    View PubMed
  5. Bajaj JS, Kamath PS, Reddy KR, Asrani SK, Keaveny AP, Tandon P, Duarte-Rojo A, Kappus M, Verna E, Biggins SW, Vargas HE, Albhaisi S, Shaw J, Dahiya M, Filipek N, Fallahzadeh MA, Wegermann K, Cabello R, Bera C, Thuluvath P, Bush B, Thacker LR, Wong F. Predictors of Respiratory Failure Development in a Multicenter Cohort of Inpatients With Cirrhosis. Am J Gastroenterol. 2024 Apr 1; 119 (4):712-718 Epub 2023 Nov 08
    View PubMed
  6. Barnhill M, Yaman R, Renszel K, Alzubaidi S, Vargas H, Chascsa D. Not Your Typical Hyperammonemia: Non-hepatic Severe Hyperammonemia in an Adult. ACG Case Rep J. 2023 Dec; 10 (12):e01225 Epub 2023 Dec 13
    View PubMed
  7. Lizaola-Mayo B, Vargas HE. Hepatorenal Syndrome-Acute Kidney Injury in Liver Transplantation. Clin Gastroenterol Hepatol. 2023 Sep; 21 (10S):S20-S26
    View PubMed
  8. Barnhill MS, Vargas HE. Immune-Checkpoint Inhibitors in the Hepatitis C-Infected Patient: To Use or Not to Use? Am J Gastroenterol 2023 Sep 1; 118 (9):1554-1555 Epub 2023 May 25
    View PubMed
  9. Velez JCQ, Wong F, Reddy KR, Sanyal AJ, Vargas HE, Curry MP, Gonzalez SA, Pappas SC, Jamil K. The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome. Kidney360. 2023 Aug 1; 4 (8):1030-1038 Epub 2023 May 05
    View PubMed
  10. Bajaj JS, Lai JC, Tandon P, O'Leary JG, Wong F, Garcia-Tsao G, Vargas HE, Kamath PS, Biggins SW, Limon-Miro A, Shaw J, Mbachi C, Chew M, Golob Deeb J, Thacker LR, Reddy KR. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis. Clin Gastroenterol Hepatol. 2023 Jul; 21 (7):1864-1872.e2 Epub 2022 Nov 01
    View PubMed
  11. Jayasekera CR, Barnhill M, Chascsa DM, Aqel B, Carey EJ, Vargas HE. Fenofibrate Improves Outcomes in Ischemic Cholangiopathy After Liver Transplantation. Gastroenterology 2023 Jun; 164 (7):1321-1323.e2 Epub 2023 Mar 06
    View PubMed
  12. Bajaj JS, Tandon P, O'Leary JG, Reddy KR, Garcia-Tsao G, Thuluvath P, Lai JC, Subramanian RM, Vargas HE, Wong F, Fagan A, McGeorge S, Thacker LR, Kamath PS. Admission Serum Metabolites and Thyroxine Predict Advanced Hepatic Encephalopathy in a Multicenter Inpatient Cirrhosis Cohort. Clin Gastroenterol Hepatol. 2023 Apr; 21 (4):1031-1040.e3 Epub 2022 Apr 15
    View PubMed
  13. Curry MP, Vargas HE, Befeler AS, Pyrsopoulos NT, Patwardhan VR, Jamil K. Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies. Hepatol Commun. 2023 Jan 1; 7 (1):e1307 Epub 2023 Jan 03
    View PubMed
  14. Cajigas HR, Burger CD, Cartin-Ceba R, DuBrock H, Swanson K, Vargas HE, Keaveny AP, Watt KD, Krowka M. Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry. Mayo Clin Proc. 2022 Dec; 97 (12):2236-2247 Epub 2022 Nov 03
    View PubMed
  15. Bajaj JS, Reddy KR, Tandon P, Garcia-Tsao G, Kamath PS, O'Leary JG, Wong F, Lai J, Vargas H, Thuluvath PJ, Subramanian RM, Pena-Rodriguez M, Sikaroodi M, Thacker LR, Gillevet PM. Association of serum metabolites and gut microbiota at hospital admission with nosocomial infection development in patients with cirrhosis. Liver Transpl. 2022 Dec; 28 (12):1831-1840 Epub 2022 Aug 26
    View PubMed
  16. Wong F, Pappas SC, Reddy KR, Vargas H, Curry MP, Sanyal A, Jamil K. Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute-on-chronic liver failure. Aliment Pharmacol Ther. 2022 Oct; 56 (8):1284-1293 Epub 2022 Aug 22
    View PubMed
  17. Wong F, Garcia-Tsao G, Reddy KR, O'Leary JG, Kamath PS, Tandon P, Lai JC, Vargas HE, Biggins SW, Fallon MB, Thuluvath PJ, Maliakkal BJ, Subramanian R, Thacker L, Bajaj JS. Prognosis of hospitalized patients with cirrhosis and acute kidney disease. Liver Int. 2022 Apr; 42 (4):896-904 Epub 2022 Jan 28
    View PubMed
  18. Aragon Pinto C, Iyer V, Almodallal YA, Albitar H, Dubrock H, Cajigas H, Heimbach JK, Rosen CB, Watt K, Taner T, Nyberg S, Vargas H, Cartin-Ceba R, Keaveny AP, Krowka M, Gallo de Moraes A. ICU and Hospital Outcomes in Patients with Hepatopulmonary Syndrome Undergoing Liver Transplantation. Lung. 2022 Feb; 200 (1):5-10 Epub 2022 Jan 10
    View PubMed
  19. Jayasekera CR, Vikram HR, Rifat Z, Wagler J, Okubo K, Braaksma BR, Harbell JW, Jadlowiec CC, Katariya NN, Mathur AK, Moss A, Reddy KS, Singer A, Orenstein R, Saling CF, Seville MT, Mour GK, Vargas HE, Byrne TJ, Hewitt WR Jr, Aqel BA. Solid Organ Transplantation From SARS-CoV-2-infected Donors to Uninfected Recipients: A Single-center Experience. Transplant Direct. 2022 Feb; 8 (2):e1286 Epub 2022 Jan 13
    View PubMed
  20. Bajaj JS, Garcia-Tsao G, Reddy KR, O'Leary JG, Vargas HE, Lai JC, Kamath PS, Tandon P, Subramanian RM, Thuluvath P, Fagan A, Sehrawat T, de la Rosa Rodriguez R, Thacker LR, Wong F. Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis. Hepatology. 2021 Nov; 74 (5):2699-2713 Epub 2021 July 08
    View PubMed
  21. O'Leary JG, Rajender Reddy K, Tandon P, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai JC, Fallon M, Vargas HE, Thuluvath P, Subramanian R, Thacker LR, Bajaj JS. Increased Risk of ACLF and Inpatient Mortality in Hospitalized Patients with Cirrhosis and Hepatic Hydrothorax. Dig Dis Sci. 2021 Oct; 66 (10):3612-3618 Epub 2020 Nov 13
    View PubMed
  22. Cartin-Ceba R, Burger C, Swanson K, Vargas H, Aqel B, Keaveny AP, Heimbach J, Taner T, Nyberg S, Rosen C, Cajigas H, DuBrock H, Krowka MJ. Clinical Outcomes After Liver Transplantation in Patients With Portopulmonary Hypertension. Transplantation. 2021 Oct 1; 105 (10):2283-2290
    View PubMed
  23. Wong F, Reddy KR, Tandon P, O'Leary JG, Garcia-Tsao G, Vargas HE, Lai JC, Biggins SW, Maliakkal B, Fallon M, Subramanian R, Thuluvath P, Kamath PS, Thacker L, Bajaj JS. Progression of Stage 2 and 3 Acute Kidney Injury in Patients With Decompensated Cirrhosis and Ascites. Clin Gastroenterol Hepatol. 2021 Aug; 19 (8):1661-1669.e2 Epub 2020 Aug 13
    View PubMed
  24. Laique SN, Zhang N, Hewitt WR, Bajaj J, Vargas HE. Increased access to liver transplantation for patients with acute on chronic liver failure after implementation of Share 35 Rule: An analysis from the UNOS database. Ann Hepatol. 2021 Jul-Aug; 23:100288 Epub 2020 Nov 18
    View PubMed
  25. Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Insurance Status But Not Race and Ethnicity Are Associated With Outcomes in a Large Hospitalized Cohort of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2021 Mar; 19 (3):565-572.e5 Epub 2020 May 08
    View PubMed
  26. Hu C, Anjur V, Saboo K, Reddy KR, O'Leary J, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Lai JC, Biggins SW, Fallon MB, Thuluvath P, Subramanian RM, Maliakkal B, Vargas H, Thacker LR, Iyer RK, Bajaj JS. Low Predictability of Readmissions and Death Using Machine Learning in Cirrhosis. Am J Gastroenterol. 2021 Feb 1; 116 (2):336-346
    View PubMed
  27. Tse CS, Yang JD, Mousa OY, Nelson KM, Pungpapong S, Keaveny A, Aqel BA, Vargas H, Dickson RC, Watt K, Gores GJ, Roberts LR, Leise MD. Direct-Acting Antiviral Therapy in Liver Transplant Patients With Hepatocellular Carcinoma and Hepatitis C. Transplant Direct. 2021 Jan; 7(1):e635. Epub 2020 Dec 08.
    View PubMed
  28. Bajaj JS, Duarte-Rojo A, Xie JJ, Acharya C, Wade JB, Robles C, Thacker LR, Flud C, Fagan A, Garcia-Saenz-de-Sicilia M, White MB, Kelly M, Nguyen V, Gavis EA, Vargas HE. Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2020 Dec; 18 (13):3008-3016.e2 Epub 2020 Mar 20
    View PubMed
  29. Bajaj JS, Reddy KR, O'Leary JG, Vargas HE, Lai JC, Kamath PS, Tandon P, Wong F, Subramanian RM, Thuluvath P, Fagan A, White MB, Gavis EA, Sehrawat T, de la Rosa Rodriguez R, Thacker LR, Sikaroodi M, Garcia-Tsao G, Gillevet PM. Serum Levels of Metabolites Produced by Intestinal Microbes and Lipid Moieties Independently Associated With Acute-on-Chronic Liver Failure and Death in Patients With Cirrhosis. Gastroenterology. 2020 Nov; 159 (5):1715-1730.e12 Epub 2020 July 17
    View PubMed
  30. Temesgen Z, Assi M, Shweta FNU, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Palraj R, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley AD. GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 Nov; 95 (11):2382-2394 Epub 2020 Sept 03
    View PubMed
  31. O'Leary JG, Tandon P, Reddy KR, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas HE, Thuluvath P, Subramanian R, Thacker LR, Bajaj JS. Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience. Dig Dis Sci. 2020 Sep; 65 (9):2571-2579 Epub 2020 Mar 07
    View PubMed
  32. Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH. An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis. Hepatology. 2020 Aug; 72 (2):441-453 Epub 2020 Apr 27
    View PubMed
  33. Temesgen Z, Assi M, Vergidis P, Rizza SA, Bauer PR, Pickering BW, Razonable RR, Libertin CR, Burger CD, Orenstein R, Vargas HE, Varatharaj Palraj BR, Dababneh AS, Chappell G, Chappell D, Ahmed O, Sakemura R, Durrant C, Kenderian SS, Badley A. First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia. medRxiv 2020 Jun 14 Epub 2020 June 14
    View PubMed
  34. Yu NY, DeWees TA, Alam M, Ochoa SA, Mangold AR, Steidley DE, Vargas HE, Golafshar MA, Schild SE, Halyard MY, Patel SH. Risk of Recurrence and 10-Year Outcomes in Surgically Treated Nonmelanoma Skin Cancer in Cardiac and Liver Transplant Recipients. Am J Clin Oncol. 2020 May; 43 (5):366-370
    View PubMed
  35. Rodriguez EA, Perez R, Zhang N, Lim ES, Miller C, Schwartz MA, McGirr AJ, Srinivasan A, Hewitt W, Silva AC, Rakela J, Vargas HE. Clinical Outcomes of Portosystemic Shunts on the Outcome of Liver Transplantation. Liver Transpl. 2020 May; 26 (5):693-701 Epub 2020 Mar 12
    View PubMed
  36. Mahdi L, Kahn A, Dhamija R, Vargas HE. Hepatic Steatosis Resulting From LMNA-Associated Familial Lipodystrophy. ACG Case Rep J. 2020 Apr; 7 (4):e00375 Epub 2020 Apr 07
    View PubMed
  37. Kawut SM, Ellenberg SS, Krowka MJ, Goldberg D, Vargas H, Koch D, Sharkoski T, Al-Naamani N, Fox A, Brown R, Levitsky J, Oh JK, Lin G, Song N, Mottram C, Doyle MF, Kaplan DE, Gupta S, Fallon MB. Sorafenib in Hepatopulmonary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Liver Transpl. 2019 Aug; 25 (8):1155-1164 Epub 2019 May 30
    View PubMed
  38. Bajaj JS, O'Leary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Biggins SW, Lai JC, Vargas HE, Maliakkal B, Fallon MB, Thuluvath PJ, Subramanian RM, Thacker LR, Reddy KR. Nosocomial Infections Are Frequent and Negatively Impact Outcomes in Hospitalized Patients With Cirrhosis. Am J Gastroenterol. 2019 Jul; 114 (7):1091-1100
    View PubMed
  39. Wong F, Reddy KR, O'Leary JG, Tandon P, Biggins SW, Garcia-Tsao G, Maliakkal BJ, Lai JC, Fallon MB, Vargas HE, Subramanian R, Thuluvath PJ, Kamath PS, Thacker L, Bajaj JS. Impact of Chronic Kidney Disease on Outcomes in Cirrhosis. Liver Transpl. 2019 Jun; 25 (6):870-880 Epub 2019 Apr 25
    View PubMed
  40. Bajaj JS, O'Leary JG, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Lai J, Fallon MB, Thuluvath PJ, Vargas HE, Maliakkal B, Subramanian RM, Thacker LR, Reddy KR. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort. Aliment Pharmacol Ther. 2019 Jun; 49 (12):1518-1527 Epub 2019 Apr 29
    View PubMed
  41. O'Leary JG, Bajaj JS, Tandon P, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai J, Fallon M, Vargas HE, Thuluvath P, Subramanian R, Thacker LR, Reddy KR. Outcomes After Listing for Liver Transplant in Patients With Acute-on-Chronic Liver Failure: The Multicenter North American Consortium for the Study of End-Stage Liver Disease Experience. Liver Transpl. 2019 Apr; 25 (4):571-579 Epub 2019 Mar 24
    View PubMed
  42. Bajaj JS, Tandon P, O'Leary JG, Wong F, Biggins SW, Garcia-Tsao G, Kamath PS, Maliakkal B, Fallon MB, Lai JC, Thuluvath PJ, Vargas HE, Subramanian RM, Thacker LR, Reddy KR. Outcomes in Patients With Cirrhosis on Primary Compared to Secondary Prophylaxis for Spontaneous Bacterial Peritonitis. Am J Gastroenterol. 2019 Apr; 114 (4):599-606
    View PubMed
  43. Bajaj JS, Vargas HE, Reddy KR, Lai JC, O'Leary JG, Tandon P, Wong F, Mitrani R, White MB, Kelly M, Fagan A, Patil R, Sait S, Sikaroodi M, Thacker LR, Gillevet PM. Association Between Intestinal Microbiota Collected at Hospital Admission and Outcomes of Patients With Cirrhosis. Clin Gastroenterol Hepatol. 2019 Mar; 17 (4):756-765.e3 Epub 2018 July 20
    View PubMed
  44. Laique SN, Vargas HE. Hepatitis C Virus: No Longer a Barrier to Oncology Care. Am J Gastroenterol 2019 Feb; 114 (2):207-208
    View PubMed
  45. Bajaj JS, Moreau R, Kamath PS, Vargas HE, Arroyo V, Reddy KR, Szabo G, Tandon P, Olson J, Karvellas C, Gustot T, Lai JC, Wong F. Acute-on-Chronic Liver Failure: Getting Ready for Prime Time? Hepatology. 2018 Oct; 68(4):1621-1632. Epub 2018 Sep 22.
    View PubMed
  46. Chascsa DM, Mousa OY, Pungpapong S, Zhang N, Chervenak A, Nidamanuri S, Rodriguez E, Franco D, Ryland K, Keaveny AP, Huskey JL, Smith M, Reddy KS, Taner CB, Vargas HE, Aqel BA. Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study. Am J Transplant. 2018 Oct; 18 (10):2559-2565 Epub 2018 June 08
    View PubMed
  47. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Sep - Oct; 17 (5):815-821
    View PubMed
  48. Bajaj JS, Tandon P, O'Leary JG, Biggins SW, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Lai JC, Fallon M, Thuluvath P, Vargas HE, Subramanian RM, Thacker LR, Reddy RK. The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis. Am J Gastroenterol. 2018 Sep; 113 (9):1339 Epub 2018 June 08
    View PubMed
  49. Aqel B, Leise M, Vargas HE, Watt KD, Keaveny AP, Zhang N, Zhang N, Pungpapong S. Multicenter Experience using Ledipasvir/Sofosbuvir +/- RBV to Treat HCV GT 1 Relapsers after Simeprevir and Sofosbuvir Treatment. Ann Hepatol. 2018 Aug 24; 17 (5):815-821
    View PubMed
  50. O'Leary JG, Reddy KR, Garcia-Tsao G, Biggins SW, Wong F, Fallon MB, Subramanian RM, Kamath PS, Thuluvath P, Vargas HE, Maliakkal B, Tandon P, Lai J, Thacker LR, Bajaj JS. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018 Jun; 67 (6):2367-2374 Epub 2018 Apr 19
    View PubMed
  51. Chascsa DM, Vargas HE. The gastroenterologist's guide to management of the post-liver transplant patient. Am J Gastroenterol. 2018 Jun; 113 (6):819-828 Epub 2018 May 11
    View PubMed
  52. Bajaj JS, Reddy RK, Tandon P, Wong F, Kamath PS, Biggins SW, Garcia-Tsao G, Fallon M, Maliakkal B, Lai J, Vargas HE, Subramanian RM, Thuluvath P, Thacker LR, O'Leary JG. Prediction of Fungal Infection Development and Their Impact on Survival Using the NACSELD Cohort. Am J Gastroenterol. 2018 Apr; 113 (4):556-563 Epub 2017 Dec 19
    View PubMed
  53. Rubin RA, Russo MW, Brown KA, Fontana RJ, Levitsky J, Vargas H, Yoshida EM, Brown RS Jr. Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study. Exp Clin Transplant. 2018 Apr; 16 (2):182-190 Epub 2016 Nov 18
    View PubMed
  54. Zeuzem S, Foster GR, Wang S, Asatryan A, Gane E, Feld JJ, Asselah T, Bourliere M, Ruane PJ, Wedemeyer H, Pol S, Flisiak R, Poordad F, Chuang WL, Stedman CA, Flamm S, Kwo P, Dore GJ, Sepulveda-Arzola G, Roberts SK, Soto-Malave R, Kaita K, Puoti M, Vierling J, Tam E, Vargas HE, Bruck R, Fuster F, Paik SW, Felizarta F, Kort J, Fu B, Liu R, Ng TI, Pilot-Matias T, Lin CW, Trinh R, Mensa FJ. Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection. N Engl J Med. 2018 Jan 25; 378 (4):354-369
    View PubMed
  55. Lok AS, Chung RT, Vargas HE, Kim AY, Naggie S, Powderly WG. Benefits of Direct-Acting Antivirals for Hepatitis C. Ann Intern Med. 2017 Dec 5; 167 (11):812-813 Epub 2017 Oct 17
    View PubMed
  56. Powderly WG, Naggie S, Kim AY, Vargas HE, Chung RT, Lok AS. IDSA/AASLD Response to Cochrane Review on Direct-Acting Antivirals for Hepatitis C. Clin Infect Dis 2017 Nov 13; 65 (11):1773-1775
    View PubMed
  57. Perez ST, Arring NM, Vargas HE, Corbett BM, Ehler S, Beck GL, Temkit M, Aqel BA, Rakela J. Improving hepatitis vaccination series completion in patients awaiting liver transplantation. Journal for Nurse Practitioners. 2017; 13 (9):e441-4
  58. Lok AS, Chung RT, Vargas HE, Kim AY, Naggie S, Powderly WG. Comments on cochrane review on direct-acting antivirals for hepatitis C. Hepatology. 2017 Oct; 66 (4):1016-1019 Epub 2017 Aug 26
    View PubMed
  59. Wong F, O'Leary JG, Reddy KR, Garcia-Tsao G, Fallon MB, Biggins SW, Subramanian RM, Thuluvath PJ, Kamath PS, Patton H, Maliakkal B, Tandon P, Vargas H, Thacker L, Bajaj JS. Acute Kidney Injury in Cirrhosis: Baseline Serum Creatinine Predicts Patient Outcomes. Am J Gastroenterol. 2017 Jul; 112 (7):1103-1110 Epub 2017 Apr 25
    View PubMed
  60. Sanyal AJ, Boyer TD, Frederick RT, Wong F, Rossaro L, Araya V, Vargas HE, Reddy KR, Pappas SC, Teuber P, Escalante S, Jamil K. Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies. Aliment Pharmacol Ther. 2017 Jun; 45 (11):1390-1402 Epub 2017 Mar 29
    View PubMed
  61. Fortune BE, Garcia-Tsao G, Ciarleglio M, Deng Y, Fallon MB, Sigal S, Chalasani NP, Lim JK, Reuben A, Vargas HE, Abrams G, Lewis MD, Hassanein T, Trotter JF, Sanyal AJ, Beavers KL, Ganger D, Thuluvath PJ, Grace ND, Groszmann RJ, Vapreotide Study Group. Child-Turcotte-Pugh Class is Best at Stratifying Risk in Variceal Hemorrhage: Analysis of a US Multicenter Prospective Study. J Clin Gastroenterol. 2017 May-Jun; 51 (5):446-453
    View PubMed
  62. Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS Jr, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, Mullhaupt B. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant. Ann Hepatol. 2017 May - Jun; 16 (3):375-381
    View PubMed
  63. Yoshida EM, Kwo P, Agarwal K, Duvoux C, Durand F, Peck-Radosavljevic M, Lilly L, Willems B, Vargas H, Kumar P, Brown RS Jr, Horsmans Y, De-Oertel S, Arterburn S, Dvory-Sobol H, Brainard DM, McHutchison JG, Terrault N, Rizzetto M, Mullhaupt B. Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant. Ann Hepatol. 2017 May - Jun; 16 (3):375-381
    View PubMed
  64. Bajaj JS, O'Leary JG, Tandon P, Wong F, Garcia-Tsao G, Kamath PS, Maliakkal B, Biggins SW, Thuluvath PJ, Fallon MB, Subramanian RM, Vargas HE, Lai J, Thacker LR, Reddy KR. Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures. Clin Gastroenterol Hepatol. 2017 Apr; 15 (4):565-574.e4 Epub 2016 Oct 05
    View PubMed
  65. Horsley-Silva JL, Vargas HE. New Therapies for Hepatitis C Virus Infection. Gastroenterol Hepatol (N Y). 2017 Jan; 13 (1):22-31
    View PubMed
  66. Kahn A, Reynolds JA, Chakkera HA, Aqel BA, Byrne TJ, Douglas DD, Moss AA, Vargas HE, Carey EJ. Prospective Analysis of Metabolic Parameters in the Detection of Diabetes and Metabolic Syndrome in Liver Transplant Recipients. Metab Syndr Relat Disord. 2016 Aug; 14 (6):305-10 Epub 2016 May 10
    View PubMed
  67. Bajaj JS, Reddy KR, Tandon P, Wong F, Kamath PS, Garcia-Tsao G, Maliakkal B, Biggins SW, Thuluvath PJ, Fallon MB, Subramanian RM, Vargas H, Thacker LR, O'Leary JG, North American Consortium for the Study of End-Stage Liver Disease. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016 Jul; 64 (1):200-8 Epub 2016 Feb 19
    View PubMed
  68. Sulkowski MS, Vargas HE, Di Bisceglie AM, Kuo A, Reddy KR, Lim JK, Morelli G, Darling JM, Feld JJ, Brown RS, Frazier LM, Stewart TG, Fried MW, Nelson DR, Jacobson IM, HCV-TARGET Study Group. Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection. Gastroenterology. 2016 Feb; 150 (2):419-29 Epub 2015 Oct 21
    View PubMed
  69. Horsley-Silva JL, Dow EN, Menias CO, Smith ML, Carballido EM, Lindor KD, Vargas HE. Docetaxel Induced Sclerosing Cholangitis. Dig Dis Sci. 2015 Oct 26. [Epub ahead of print]
    View PubMed
  70. Aqel BA, Pungpapong S, Leise M, Werner KT, Chervenak AE, Watt KD, Murphy JL, Ryland K, Keaveny AP, McLemore R, Vargas HE. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 in patients with cirrhosis. Hepatology. 2015 Oct; 62 (4):1004-12 Epub 2015 Aug 07
    View PubMed
  71. Chung RT, Davis GL, Jensen DM, Masur H, Saag MS, Thomas DL, Aronsohn AI, Charlton MR, Feld JJ, Fontana RJ, Ghany MG, Godofsky EW, Graham CS, Kim AY, Kiser JJ, Kottilil S, Marks KM, Martin P, Mitruka K, Morgan TR, Naggie S, Raymond D, Reau NS, Schooley RT, Sherman KE, Sulkowski MS, Vargas HE, Ward JW, Wyles DL. Hepatitis c guidance: aasld-idsa recommendations for testing, managing, and treating adults infected with hepatitis c virus. Hepatology. 2015 Sep; 62(3):932-54.
    View PubMed
  72. Charlton M, Everson GT, Flamm SL, Kumar P, Landis C, Brown RS Jr, Fried MW, Terrault NA, O'Leary JG, Vargas HE, Kuo A, Schiff E, Sulkowski MS, Gilroy R, Watt KD, Brown K, Kwo P, Pungpapong S, Korenblat KM, Muir AJ, Teperman L, Fontana RJ, Denning J, Arterburn S, Dvory-Sobol H, Brandt-Sarif T, Pang PS, McHutchison JG, Reddy KR, Afdhal N, SOLAR-1 Investigators. Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease. Gastroenterology. 2015 Sep; 149 (3):649-59 Epub 2015 May 15
    View PubMed
  73. Horsley-Silva JL, Vargas HE. Gastrointestinal endoscopy in the cirrhotic patient. Expert Rev Gastroenterol Hepatol. 2015 Jul; 9 (7):1005-13 Epub 2015 May 12
    View PubMed
  74. Pungpapong S, Aqel B, Leise M, Werner KT, Murphy JL, Henry TM, Ryland K, Chervenak AE, Watt KD, Vargas HE, Keaveny AP. Multicenter experience using simeprevir and sofosbuvir with or without ribavirin to treat hepatitis C genotype 1 after liver transplant. Hepatology. 2015 Jun; 61 (6):1880-6 Epub 2015 Apr 27
    View PubMed
  75. Aqel BA, Vargas HE. Hepatitis C virus infection in nonliver solid organ transplant candidates and recipients. Curr Opin Organ Transplant. 2015 Jun; 20 (3):259-66
    View PubMed
  76. Batheja M, Vargas H, Silva AM, Walker F, Chang YH, De Petris G, Silva AC. Magnetic resonance elastography (MRE) in assessing hepatic fibrosis: performance in a cohort of patients with histological data. Abdom Imaging. 2015 Apr; 40: (4)760-5.
    View PubMed
  77. Yadav A, Vargas HE. Care of the patient with cirrhosis. Clin Liver Dis (Hoboken). 2015 Apr; 5 (4):100-104 Epub 2015 May 07
    View PubMed
  78. Yadav A, Chang YH, Carpenter S, Silva AC, Rakela J, Aqel BA, Byrne TJ, Douglas DD, Vargas HE, Carey EJ. Relationship between sarcopenia, six-minute walk distance and health-related quality of life in liver transplant candidates. Clin Transplant. 2015 Feb; 29(2):134-41. Epub 2015 Jan 09.
    View PubMed
  79. Gordon SC, Muir AJ, Lim JK, Pearlman B, Argo CK, Ramani A, Maliakkal B, Alam I, Stewart TG, Vainorius M, Peter J, Nelson DR, Fried MW, Reddy KR, on behalf of the HCV-TARGET study group. Safety profile of boceprevir and telaprevir in chronic hepatitis C: Real world experience from HCV-TARGET. Journal of Hepatology. 2015; 62:286-93.
  80. Kwo PY, Mantry PS, Coakley E, Te HS, Vargas HE, Brown R Jr, Gordon F, Levitsky J, Terrault NA, Burton JR Jr, Xie W, Setze C, Badri P, Pilot-Matias T, Vilchez RA, Forns X. An interferon-free antiviral regimen for HCV after liver transplantation. N Engl J Med. 2014 Dec 18; 371 (25):2375-82 Epub 2014 Nov 11
    View PubMed
  81. Gallegos-Orozco JF, Silva AC, Batheja MJ, Chang YH, Hansen KL, Lam-Himlin D, De Petris G, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan DC, Silva AM, Rakela J, Vargas HE. Magnetic resonance elastography can discriminate normal vs. abnormal liver biopsy in candidates for live liver donation. Abdom Imaging. 2014 Dec 02.
    View PubMed
  82. Terrault NA, Hassanein T, Howell CD, Joshi S, Lake J, Sher L, Vargas H, McIntosh J, Tang S, Jenkins TM. Phase II study of avatrombopag in thrombocytopenic patients with cirrhosis undergoing an elective procedure. J Hepatol. 2014 Dec; 61 (6):1253-9 Epub 2014 July 15
    View PubMed
  83. Muir AJ, Arora S, Everson G, Flisiak R, George J, Ghalib R, Gordon SC, Gray T, Greenbloom S, Hassanein T, Hillson J, Horga MA, Jacobson IM, Jeffers L, Kowdley KV, Lawitz E, Lueth S, Rodriguez-Torres M, Rustgi V, Shemanski L, Shiffman ML, Srinivasan S, Vargas HE, Vierling JM, Xu D, Lopez-Talavera JC, Zeuzem S, EMERGE study group. A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection. J Hepatol. 2014 Dec; 61 (6):1238-46 Epub 2014 July 24
    View PubMed
  84. Ratuapli SK, Vargas HE. Colonoscopy in liver disease. Clin Liver Dis (Hoboken). 2014 Nov; 4 (5):109-112 Epub 2014 Dec 09
    View PubMed
  85. Corey RL, Whitaker MD, Crowell MD, Keddis MT, Aqel B, Balan V, Byrne T, Carey E, Douglas DD, Harrison ME, Vargas HE, Rakela J. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation. Clin Transplant. 2014 May; 28 (5):579-84 Epub 2014 Apr 21
    View PubMed
  86. Manns MP, Vierling JM, Bacon BR, Bruno S, Shibolet O, Baruch Y, Marcellin P, Caro L, Howe AYM, Fandozzi C, Gress J, Gilbert CL, Shaw PM, Cooreman MP, Robertson MN, Hwang P, Dutko FJ, Wahl J, Mobashery N, Investigators. The Combination of MK-5172, Peginterferon, and Ribavirin is Effective in Treatment-Naive Patients with Hepatitis C Virus Genotype 1 Infection without Cirrhosis. Gastroenterology. 2014; 147(2):366-76.
  87. Klintmalm GB, Feng S, Lake JR, Vargas HE, Wekerle T, Agnes S, Brown KA, Nashan B, Rostaing L, Meadows-Shropshire S, Agarwal M, Harler MB, García-Valdecasas JC. Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant. 2014; 14(8):1817-27.
    View PubMed
  88. Unzueta A, Vargas HE. Nonsteroidal anti-inflammatory drug-induced hepatoxicity. Clin Liver Dis. 2013 Nov; 17 (4):643-56, ix Epub 2013 Sept 04
    View PubMed
  89. Pungpapong S, Aqel BA, Koning L, Murphy JL, Henry TM, Ryland KL, Yataco ML, Satyanarayana R, Rosser BG, Vargas HE, Charlton MR, Keaveny AP. Multicenter experience using telaprevir or boceprevir with peginterferon and ribavirin to treat hepatitis C genotype 1 after liver transplantation. Liver Transpl. 2013 Jul; 19 (7):690-700 Epub 2013 June 03
    View PubMed
  90. Werner KT, Sando S, Carey EJ, Vargas HE, Byrne TJ, Douglas DD, Harrison ME, Rakela J, Aqel BA. Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci. 2013 Jun; 58 (6):1776-80 Epub 2013 Jan 12
    View PubMed
  91. Hsieh TH, Mekeel KL, Crowell MD, Nguyen CC, Das A, Aqel BA, Carey EJ, Byrne TJ, Vargas HE, Douglas DD, Mulligan DC, Harrison ME. Endoscopic treatment of anastomotic biliary strictures after living donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc. 2013 Jan; 77 (1):47-54 Epub 2012 Oct 11
    View PubMed
  92. Yadav AD, Chang YH, Aqel BA, Byrne TJ, Chakkera HA, Douglas DD, Mulligan DC, Rakela J, Vargas HE, Carey EJ. New Onset Diabetes Mellitus in Living Donor versus Deceased Donor Liver Transplant Recipients: Analysis of the UNOS/OPTN Database. J Transplant. 2013; 2013:269096 Epub 2013 Sept 24
    View PubMed
  93. Gordon FD, Kwo P, Ghalib R, Crippin J, Vargas HE, Brown KA, Schiano T, Chaudhri E, Pedicone LD, Brown RS Jr. Peginterferon-alpha-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantation. J Clin Gastroenterol. 2012 Sep; 46(8):700-8.
    View PubMed
  94. Lalezari J, Asmuth D, Casiro A, Vargas H, Lawrence S, Dubuc-Patrick G, Chen J, McCarville J, Pietropaolo K, Zhou XJ, Sullivan-Bolyai J, Mayerse D. Short-term monotherapy with IDX184, a liver-targeted nucleotide polymerase inhibitor, in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother. 2012; 56(12):6372-8.
    View PubMed
  95. Carey EJ, Aqel BA, Byrne TJ, Douglas DD, Rakela J, Vargas HE, Moss AA, Mulligan DC, Reddy KS, Chakkera HA. Pretransplant fasting glucose predicts new-onset diabetes after liver transplantation. J Transplant. 2012; 2012:614781 Epub 2012 Jan 29
    View PubMed
  96. Klintmalm GB, Davis GL, Teperman L, Netto GJ, Washburn K, Rudich SM, Pomfret EA, Vargas HE, Brown R, Eckhoff D, Pruett TL, Roberts J, Mulligan DC, Charlton MR, Heffron TG, Ham JM, Douglas DD, Sher L, Baliga PK, Kinkhabwala M, Koneru B, Abecassis M, Millis M, Jennings LW, Fasola CG. A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl. 2011 Dec; 17(12):1394-403.
    View PubMed
  97. Martin KA, Bostwick JM, Vargas HE. Liver transplant case report: Transgenderism and liver transplantation. International Journal of Transgenderism. 2011 Oct; 13(1):45-9.
  98. Carey EJ, Steidley DE, Aqel BA, Byrne TJ, Mekeel KL, Rakela J, Vargas HE, Douglas DD. Six-minute walk distance predicts mortality in liver transplant candidates. Liver Transpl. 2010 Dec; 16 (12):1373-8
    View PubMed
  99. Werner T, Aqel B, Balan V, Byrne T, Carey E, Douglas D, Heilman RL, Rakela J, Mekeel K, Reddy K, Vargas HE. Treatment of hepatitis C in renal transplantation candidates: a single-center experience. Transplantation. 2010 Aug 27; 90 (4):407-11
    View PubMed
  100. Eleid MF, Hurst RT, Vargas HE, Rakela J, Mulligan DC, Appleton CP. Short-term cardiac and noncardiac mortality following liver transplantation. J Transplant. 2010; 2010 Epub 2010 Aug 12
    View PubMed
  101. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl. 2009 Dec; 15 (12):1872-81
    View PubMed
  102. Singh V, Rudraraju M, Carey EJ, Byrne TJ, Douglas DD, Rakela J, Vargas HE. An unusual occurrence of giant cell hepatitis. Liver Transpl. 2009 Dec; 15(12):1888-90.
    View PubMed
  103. Gallegos-Orozco JF, Vargas HE. Liver transplantation: from Child to MELD. Med Clin North Am. 2009 Jul; 93 (4):931-50, ix
    View PubMed
  104. Silva AC, Evans JM, McCullough AE, Jatoi MA, Vargas HE, Hara AK. MR imaging of hypervascular liver masses: a review of current techniques. Radiographics. 2009 Mar-Apr; 29 (2):385-402
    View PubMed
  105. Gurudu SR, Vargas HE, Leighton JA. New frontiers in small-bowel imaging: the expanding technology of capsule endoscopy and its impact in clinical gastroenterology. Rev Gastroenterol Disord. 2008 Winter; 8(1):1-14.
    View PubMed
  106. Gallegos-Orozco JF, Rakela J, Rosati MJ, Vargas HE, Balan V. Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy. Dig Dis Sci. 2008 Sep; 53 (9):2564-8 Epub 2008 July 02
    View PubMed
  107. Carey EJ, Vargas HE, Douglas DD, Balan V, Byrne TJ, Harrison ME, Rakela J. Inpatient admissions for drug-induced liver injury: results from a single center. Dig Dis Sci. 2008 Jul; 53 (7):1977-82 Epub 2008 Apr 05
    View PubMed
  108. Umphrey LG, Hurst RT, Eleid MF, Lee KS, Reuss CS, Hentz JG, Vargas HE, Appleton CP. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl. 2008 Jun; 14(6):886-92.
    View PubMed
  109. Mekeel KL, Moss AA, Reddy KS, Douglas DD, Vargas HE, Carey EJ, Byrne TJ, Harrison ME, Rakela J, Mulligan DC. Living donor liver transplantation in polycystic liver disease. Liver Transpl. 2008 May; 14(5):680-3.
    View PubMed
  110. de Franchis R, Eisen GM, Laine L, Fernandez-Urien I, Herrerias JM, Brown RD, Fisher L, Vargas HE, Vargo J, Thompson J, Eliakim R. Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension. Hepatology. 2008 May; 47(5):1595-603.
    View PubMed
  111. Rodriguez-Luna H, Vargas HE. Portal vein thrombosis. Curr Treat Options Gastroenterol. 2007 Dec; 10 (6):435-43
    View PubMed
  112. Lee HR, Hurst RT, Vargas HE. Transient left ventricular apical ballooning syndrome (Takotsubo cardiomyopathy) following orthotopic liver transplantation. Liver Transpl. 2007 Sep; 13(9):1343-5.
    View PubMed
  113. McCashland T, Watt K, Lyden E, Adams L, Charlton M, Smith AD, McGuire BM, Biggins SW, Neff G, Burton JR Jr, Vargas H, Donovan J, Trotter J, Faust T. Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl. 2007 Sep; 13(9):1246-53.
    View PubMed
  114. Pasha SF, Harrison ME, Das A, Nguyen CC, Vargas HE, Balan V, Byrne TJ, Douglas DD, Mulligan DC. Endoscopic treatment of anastomotic biliary strictures after deceased donor liver transplantation: outcomes after maximal stent therapy. Gastrointest Endosc. 2007 Jul; 66 (1):44-51
    View PubMed
  115. Werner T, Vargas HE, Chalasani N. Macro-aspartate aminotransferase and monoclonal gammopathy: a review of two cases. Dig Dis Sci. 2007 May; 52 (5):1197-8 Epub 2007 Mar 15
    View PubMed
  116. Cheruvattath R, Rosati MJ, Gautam M, Vargas HE, Rakela J, Balan V. Pegylated interferon and ribavirin failures: is retreatment an option? Dig Dis Sci. 2007 Mar; 52 (3):732-6
    View PubMed
  117. Gallegos-Orozco JF, Vargas HE. Should antihepatitis B virus core positive or antihepatitis C virus core positive subjects be accepted as organ donors for liver transplantation? J Clin Gastroenterol. 2007 Jan; 41(1):66-74.
    View PubMed
  118. Cheruvattath R, Orrego M, Gautam M, Byrne T, Alam S, Voltchenok M, Edwin M, Wilkens J, Williams JW, Vargas HE. Vitamin A toxicity: when one a day doesn't keep the doctor away. Liver Transpl. 2006 Dec; 12: (12)1888-91.
    View PubMed
  119. Vargas HE. A difficult case of primary sclerosing cholangitis. Liver Transpl. 2006 Nov; 12(11 Suppl 2):S65-7.
    View PubMed
  120. Gallegos-Orozco JF, Arenas JI, Vargas HE, Kibler KV, Wilkinson JK, Nowicki M, Radkowski M, Nasseri J, Rakela J, Laskus T. Selection of different 5' untranslated region hepatitis C virus variants during post-transfusion and post-transplantation infection. J Viral Hepat. 2006 Jul; 13 (7):489-98
    View PubMed
  121. Sachdev M, Hernandez JL, Sharma P, Douglas DD, Byrne T, Harrison ME, Mulligan D, Moss A, Reddy K, Vargas HE, Rakela J, Balan V. Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci. 2006 Jun; 51 (6):1070-8
    View PubMed
  122. Orrego M, Vargas HE, Balan V, Wells C, Harrison ME, Larson J, Huettl E, Liu PT. Portal hypertension due to a splenic arteriovenous fistula: a case report. Dig Dis Sci. 2006 Jun; 51 (6):1113-6
    View PubMed
  123. Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl. 2006 Apr; 12(4):560-5.
    View PubMed
  124. Rodriguez-Luna H, Vargas HE, Moss A, Reddy KS, Freeman RB, Mulligan D. Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant. 2005 Sep; 5 (9):2244-7
    View PubMed
  125. Orrego M, Guo L, Reeder C, De Petris G, Balan V, Douglas DD, Byrne T, Harrison E, Mulligan D, Rodriguez-Luna H, Moss A, Reddy K, Rakela J, Vargas HE. Hepatic B-cell non-Hodgkin's lymphoma of MALT type in the liver explant of a patient with chronic hepatitis C infection. Liver Transpl. 2005 Jul; 11 (7):796-799
    View PubMed
  126. Rodriguez-Luna H, Vargas HE, Byrne T, Rakela J. Artificial neural network and tissue genotyping of hepatocellular carcinoma in liver-transplant recipients: prediction of recurrence. Transplantation. 2005 Jun 27; 79 (12):1737-40
    View PubMed
  127. Rodriguez-Luna H, Vargas HE. Management of hepatitis C virus infection in the setting of liver transplantation. Liver Transpl. 2005 May; 11(5):479-89.
    View PubMed
  128. Gallegos-Orozco JF, Vargas HE, Rakela J. Virologically compromised donor grafts in liver transplantation. J Hepatol. 2004 Oct; 41(4):512-21.
    View PubMed
  129. Laskus T, Wilkinson J, Gallegos-Orozco JF, Radkowski M, Adair DM, Nowicki M, Operskalski E, Buskell Z, Seeff LB, Vargas H, Rakela J. Analysis of hepatitis C virus quasispecies transmission and evolution in patients infected through blood transfusion. Gastroenterology. 2004 Sep; 127 (3):764-76
    View PubMed
  130. Arenas JI, Vargas HE. Hepatitis C virus antiviral therapy in patients with cirrhosis. Gastroenterol Clin North Am. 2004 Sep; 33 (3):549-62, ix
    View PubMed
  131. Rodriguez-Luna H, Balan V, Sharma P, Byrne T, Mulligan D, Rakela J, Vargas HE. Hepatitis C virus infection with hepatocellular carcinoma: not a controversial indication for liver transplantation. Transplantation. 2004 Aug 27; 78 (4):580-3
    View PubMed
  132. Rodriguez-Luna H, Vargas HE, Williams J, De Petris G, Rakela J, Douglas DD. Primary biliary cirrhosis and systemic amyloidosis, a new association. Dig Dis Sci. 2004 Aug; 49 (7-8):1196-200
    View PubMed
  133. Arenas JI, Gallegos-Orozco JF, Laskus T, Wilkinson J, Khatib A, Fasola C, Adair D, Radkowski M, Kibler KV, Nowicki M, Douglas D, Williams J, Netto G, Mulligan D, Klintmalm G, Rakela J, Vargas HE. Hepatitis C virus quasi-species dynamics predict progression of fibrosis after liver transplantation. J Infect Dis. 2004 Jun 1; 189(11):2037-46.
    View PubMed
  134. Carey EJ, Douglas DD, Balan V, Vargas HE, Byrne TJ, Moss AA, Mulligan DC. Hepatopulmonary syndrome after living donor liver transplantation and deceased donor liver transplantation: a single-center experience. Liver Transpl. 2004 Apr; 10: (4)529-33.
    View PubMed
  135. Rodriguez-Luna H, Vargas HE. Natural history of hepatitis C and outcomes following liver transplantation. Minerva Gastroenterol Dietol. 2004 Mar; 50(1):51-9.
    View PubMed
  136. Rodriguez-Luna H, Khatib A, Sharma P, De Petris G, Williams JW, Ortiz J, Hansen K, Mulligan D, Moss A, Douglas DD, Balan V, Rakela J, Vargas HE. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylated interferon alpha2b and ribavirin: an open-label series. Transplantation. 2004 Jan 27; 77 (2):190-4
    View PubMed
  137. Sharma P, Balan V, Hernandez J, Rosati M, Williams J, Rodriguez-Luna H, Schwartz J, Harrison E, Anderson M, Byrne T, Vargas HE, Douglas DD, Rakela J. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors? Dig Dis Sci. 2004 Jan; 49 (1):25-9
    View PubMed
  138. Rodriguez-Luna H, Vargas HE, Sharma P, Ortiz J, De Petris G, Balan V, Byrne T, Moss A, Mulligan D, Rakela J, Douglas DD. Hepatitis C virus recurrence in living donor liver transplant recipients. Dig Dis Sci. 2004 Jan; 49 (1):38-41
    View PubMed
  139. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Byrne T, Vargas HE, Mulligan D, Rakela J, Wiesner RH. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transpl. 2004 Jan; 10(1):36-41.
    View PubMed
  140. Fontana RJ, Everson GT, Tuteja S, Vargas HE, Shiffman ML. Controversies in the management of hepatitis C patients with advanced fibrosis and cirrhosis. Clin Gastroenterol Hepatol. 2004; 2:183-197.
    View PubMed
  141. Gallegos-Orozco JF, Vargas HE. Recurrent hepatitis C virus after liver transplantation: The role of quasispecies complexity and diversity. Curr Opin Organ Transplant. 2004; 9(2):103.
  142. Chopra KB, Demetris AJ, Blakolmer K, Dvorchik I, Laskus T, Wang LF, Araya VR, Dodson F, Fung JJ, Rakela J, Vargas HE. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation. Transplantation. 2003 Nov 27; 76(10):1487-91.
    View PubMed
  143. Shiffman ML, Vargas HE, Everson GT. Controversies in the management of hepatitis C virus infection after liver transplantation. Liver Transpl. 2003 Nov; 9(11):1129-44.
    View PubMed
  144. Arenas JI, Vargas HE, Rakela J. The use of hepatitis C-infected grafts in liver transplantation. Liver Transpl. 2003 Nov; 9(11 Suppl 3):S48-S51.
    View PubMed
  145. Rodriguez-Luna H, Arenas J, Vargas HE. The use of virologically compromised organs in liver transplantation. Clin Liver Dis. 2003 Aug; 7 (3):573-84, vi
    View PubMed
  146. Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl. 2002 Nov; 8 (11):1014-9
    View PubMed
  147. Rakela J, Vargas HE. Hepatitis C: Magnitude of the problem. Liver Transpl. 2002 Oct; 8(10 Suppl 1):S3-6.
    View PubMed
  148. Laskus T, Radkowski M, Bednarska A, Wilkinson J, Adair D, Nowicki M, Nikolopoulou GB, Vargas H, Rakela J. Detection and analysis of hepatitis C virus sequences in cerebrospinal fluid. J Virol. 2002 Oct; 76 (19):10064-8
    View PubMed
  149. Joya-Vazquez PP, Dodson FS, Dvorchik I, Gray E, Chesky A, Demetris AJ, Shakil O, Fung JJ, Vargas HE. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002 May 27; 73(10):1598-602.
    View PubMed
  150. Laskus T, Radkowski M, Wilkinson J, Vargas H, Rakela J. The origin of hepatitis C virus reinfecting transplanted livers: Serum-derived versus peripheral blood mononuclear cell-derived virus. J Infect Dis. 2002 Feb 15; 185(4):417-21.
    View PubMed
  151. Vargas HE, Dodson FS, Rakela J. A concise update on the status of liver transplantation for hepatitis B virus: the challenges in 2002. Liver Transpl. 2002 Jan; 8: (1)2-9.
    View PubMed
  152. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol. 2002 Jan; 76 (2):600-8
    View PubMed
  153. Arenas JI Fasola CG Rakela J Wilkinson JK, Laskus T, Vargas H, Klintmalm G. Analysis Of 5'UTR And E2 Region Quasispecies In Liver Transplantation. Gastroenterology. 2002; 123:80.
  154. Ahmad J, Vargas H, Balan V, Rakela J, Shakil AO. A randomized, double-blind, placebo-controlled trial of interferon-alpha and amantidine versus interferon-alpha alone in the treatment of patients with chronic hepatitis C. Dig Dis Sci. 2002; 47(7):1655-6.
    View PubMed
  155. Radkowski M, Wang LF, Vargas H, Wilkinson J, Vargas H, Rakela J, Laskus T. Changes in hepatitis C virus population in serum and peripheral blood mononuclear cells in chronically infected patients receiving liver graft from infected donors. Transplantation. 2001 Sep 15; 72 (5):833-8
    View PubMed
  156. Kashyap R, Jain A, Nalesnik M, Carr B, Barnes J, Vargas HE, Rakela J, Fung J. Clinical significance of elevated alpha-fetoprotein in adults and children. Dig Dis Sci. 2001 Aug; 46(8):1709-13.
    View PubMed
  157. Vargas HE. The real danger of lamivudine-resistant hepatitis B virus infection in the immunocompromised host. Liver Transpl. 2001 Mar; 7(3):279-81.
    View PubMed
  158. Laskus T, Wang LF, Radkowski M, Vargas H, Nowicki M, Wilkinson J, Rakela J. Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain. J Virol. 2001 Mar; 75 (5):2059-66
    View PubMed
  159. De Vera ME, Reyes J, Mazariegos G, Schaefer N, Vargas H, Bond G, Wu T, Fung J, Starzl TE, Abu-Elmagd K. Isolated intestinal versus composite visceral allografts: causes of graft failure. Transplant Proc. 2000; 32:1221-2.
    View PubMed
  160. Vargas HE, Whitcomb DC. Hepatitis C For Half A Century. Gastroenterology. 2000; 119:1405-1407.
    View PubMed
  161. Paterson DL, Gayowski T, Wannstedt CF, Wagener MM, Marino IR, Vargas H, Laskus T, Rakela J, Singh, N. Quality of life in long-term survivors after liver transplantation: impact of recurrent viral hepatitis C virus hepatitis. Clin Transplant. 2000; 14(1):48-54.
    View PubMed
  162. Gayowski, T, Singh, N, Keyes L, Wannstedt CF, Wagener MM, Vargas HE, Laskus T, Rakela J, Fung JJ, Marino IR. Late-onset renal failure after liver transplantation: role of posttransplant alcohol use. Transplantation. 2000; 69(3):383-8.
    View PubMed
  163. Taniguchi M, Shakil AO, Vargas HE, Laskus T, Demetris AJ, Gayowski T, Dodson SF, Fung JJ, Rakela J. Clinical and virological response of hepatitis B and C viral co-infection after liver transplantation: effect of viral hepatitis D. Liver Transpl Surg. 2000; 6(1):92-6.
  164. Vargas HE, Laskus T, Wang LF, Lee R, Radkowski M, Dodson F, Fung JJ, Rakela J. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts. Gastroenterology. 1999 Jul; 117(1):149-53.
    View PubMed
  165. Vargas HE, Rakela J. Liver transplantation for variceal hemorrhage. Gastrointest Endosc Clin N Am. 1999 Apr; 9(2):347-53.
    View PubMed
  166. Radkowski M, Wang LF, Vargas H, Rakela J, Laskus T. Hepatitis C virus in peripheral blood mononuclear cells from a chronically infected patient receiving liver graft from infected donor. Transplantation. 1999 Feb 27; 67(4):627-9.
    View PubMed
  167. Vargas HE, Gerber D, Abu-Elmagd K. Management of portal hypertension-related bleeding. Surg Clin North Am. 1999 Feb; 79(1):1-22.
    View PubMed
  168. Chopra K, Vargas H, Demetris A, Blakolmer K, Dvorchick I, Laskus T, Wang LF, Araya V, Dodson F, Fung J, Rakela J. Progression of liver fibrosis in patients with chronic hepatitis C after orthotopic liver transplantation: a final report. Hepatology. 1999; 30(4):331.
  169. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Search for hepatitis C virus extrahepatic replication sites in patients with acquired immunodeficiency syndrome: specific detection of negative- strand viral RNA in various tissues. Hepatology. 1998 Nov; 28(5):1398-401.
    View PubMed
  170. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. J Infect Dis. 1998 Oct; 178(4):1189-92.
    View PubMed
  171. Radkowski M, Wang LF, Vargas HE, Rakela J, Laskus T. Detection of hepatitis C virus replication in peripheral blood mononuclear cells after orthotopic liver transplantation. Transplantation. 1998 Sep 15; 66(5):664-6.
    View PubMed
  172. Laskus T, Radkowski M, Wang LF, Jang SJ, Vargas H, Rakela J. Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology. 1998 Aug 15; 248(1):164-71.
    View PubMed
  173. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Detection of hepatitis G virus replication sites by using highly strand-specific Tth-based reverse transcriptase PCR. J Virol. 1998 Apr; 72(4):3072-5.
    View PubMed
  174. Laskus T, Radkowski M, Nowicki M, Wang LF, Vargas H, Rakela J. Association between hepatitis B virus core promoter rearrangements and hepatocellular carcinoma. Biochem Biophys Res Commun. 1998 Mar 27; 244(3):812-4.
    View PubMed
  175. Radkowski M, Wang LF, Vargas H, Rakela J, Laskus T. Lack of evidence for GB virus C/hepatitis G virus replication in peripheral blood mononuclear cells. J Hepatol. 1998 Feb; 28(2):179-83.
    View PubMed
  176. Vargas HE, Laskus T, Wang LF, Radkowski M, Poutous A, Lee R, Demetris JA, Gayowski T, Marino IR, Singh N, Dodson F, Casavilla A, Fung JJ, Rakela J. The influence of hepatitis C virus genotypes on the outcome of liver transplantation. Liver Transpl Surg. 1998 Jan; 4(1):22-7.
    View PubMed
  177. Laskus T, Wang LF, Radkowski M, Jang SJ, Vargas H, Dodson F, Fung J, Rakela J. Hepatitis G virus infection in American patients with cryptogenic cirrhosis: no evidence for liver replication. J Infect Dis. 1997 Dec; 176(6):1491-5.
    View PubMed
  178. Wang LF, Radkowski M, Vargas H, Rakela J, Laskus T. Amplification and fusion of long fragments of hepatitis C virus genome. J Virol Methods. 1997 Nov; 68(2):217-23.
    View PubMed
  179. Laskus T, Radkowski M, Wang LF, Vargas H, Rakela J. Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol. 1997 Oct; 71(10):7804-6.
    View PubMed
  180. Vargas HE, Laskus T, Radkowski M, Poutous A, Wang LF, Lee R, Dodson F, Gayowski T, Singh N, Marino IR, Fung JJ, Zhang-Keck ZY, Kim JP, Rakela J. Hepatitis G virus coinfection in hepatitis C virus-infected liver transplant recipients. Transplantation. 1997 Sep 15; 64(5):786-8.
    View PubMed
  181. Gayowski T, Singh N, Marino IR, Vargas H, Wagener M, Wannstedt C, Morelli F, Laskus T, Fung JJ, Rakela J, Starzl TE. Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome. Transplantation. 1997 Aug 15; 64(3):422-6.
    View PubMed
  182. Laskus T, Wang LF, Radkowski M, Vargas H, Cianciara J, Poutous A, Rakela J. Comparison of hepatitis B virus core promoter sequences in peripheral blood mononuclear cells and serum from patients with hepatitis B. J Gen Virol. 1997 Mar; 78(Pt 3):649-53.
    View PubMed
  183. Vargas HE, Wang LF, Laskus T, Poutous A, Lee R, Demetris A, Dodson F, Casavilla A, Fung J, Gayowski T, Singh N, Marino I, Rakela J. Distribution of infecting hepatitis C virus genotypes in end-stage liver disease patients at a large American transplantation center. J Infect Dis. 1997 Feb; 175(2):448-50.
    View PubMed
  184. Laskus T, Wang LF, Rakela J, Vargas H, Pinna AD, Tsamandas AC, Demetris AJ, Fung J. Dynamic behavior of hepatitis C virus in chronically infected patients receiving liver graft from infected donors. Virology. 1996 Jun 1; 220(1):171-6.
    View PubMed
  185. DiSario JA, Burt RW, Vargas H, McWhorter WP. Small bowel cancer: epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol. 1994 May; 89(5):699-701.
    View PubMed
  186. Hubbell HR, Vargas HE, Tsujimoto KL, Gibson GD, Pequignot EC, Bigler RD, Carter WA, Strayer DR. Antitumor effects of interleukin-2 and mismatched double-stranded RNA, individually and in combination, against a human malignant melanoma xenograft. Cancer Immunol Immunother. 1992; 35(3):151-7.
    View PubMed
PST-20220907